Delaware County Tracking Substance Use Through Sewage [Video]
Alex Buben from Biobot Analytics discusses the wastewater-based monitoring program for high-risk substances.
Alex Buben from Biobot Analytics discusses the wastewater-based monitoring program for high-risk substances.
By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….
Nov 2 (Reuters) – CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line. CVS said on Wednesday it had agreed…
Brain Mann | NPR Dec. 13, 2022 Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription. The medication, an easy-to-use nasal spray version of the drug naloxone, has a strong track record reversing deadly opioid overdoses, which have soared in…
Please view the 2024 National Fentanyl Awareness Day commemoration (starts at 54:46 minutes into the Marin Board of Supervisors’ meeting on 5/7/24.) This segment (#4 in the agenda) includes updates from Supervisor Katie Rice (who sponsored the resolution) and Public Health Officer Matthew Willis, MPH, MD, as well as input from interns, the community and…
I still feel the pain of losing my brother to a fatal opioid overdose in 2018. Jerry was only 50. It was at that moment that I committed to being an advocate for overdose death prevention in my home county of Marin. Earlier this month, the Marin Independent Journal highlighted the story of Aidan Mullin,…
The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified…
By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….
Nov 2 (Reuters) – CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line. CVS said on Wednesday it had agreed…
Brain Mann | NPR Dec. 13, 2022 Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription. The medication, an easy-to-use nasal spray version of the drug naloxone, has a strong track record reversing deadly opioid overdoses, which have soared in…
Please view the 2024 National Fentanyl Awareness Day commemoration (starts at 54:46 minutes into the Marin Board of Supervisors’ meeting on 5/7/24.) This segment (#4 in the agenda) includes updates from Supervisor Katie Rice (who sponsored the resolution) and Public Health Officer Matthew Willis, MPH, MD, as well as input from interns, the community and…
I still feel the pain of losing my brother to a fatal opioid overdose in 2018. Jerry was only 50. It was at that moment that I committed to being an advocate for overdose death prevention in my home county of Marin. Earlier this month, the Marin Independent Journal highlighted the story of Aidan Mullin,…
The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified…
By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….
Nov 2 (Reuters) – CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs, potentially bringing years of litigation close to the finish line. CVS said on Wednesday it had agreed…
Brain Mann | NPR Dec. 13, 2022 Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription. The medication, an easy-to-use nasal spray version of the drug naloxone, has a strong track record reversing deadly opioid overdoses, which have soared in…
Please view the 2024 National Fentanyl Awareness Day commemoration (starts at 54:46 minutes into the Marin Board of Supervisors’ meeting on 5/7/24.) This segment (#4 in the agenda) includes updates from Supervisor Katie Rice (who sponsored the resolution) and Public Health Officer Matthew Willis, MPH, MD, as well as input from interns, the community and…
I still feel the pain of losing my brother to a fatal opioid overdose in 2018. Jerry was only 50. It was at that moment that I committed to being an advocate for overdose death prevention in my home county of Marin. Earlier this month, the Marin Independent Journal highlighted the story of Aidan Mullin,…
The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified…